VCEL - Vericel Corp Stock Price, Fair Value and News

$56.50+1.55 (+2.82%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

VCEL Price Action

Last 7 days

-1.7%

Last 30 days

-1.3%

Last 90 days

21.3%

Trailing 12 Months

59.2%

VCEL RSI Chart

VCEL Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

786.01

Price/Sales (Trailing)

12.29

EV/EBITDA

129.97

Price/Free Cashflow

-232.11

VCEL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VCEL Fundamentals

VCEL Revenue

Revenue (TTM)

226.8M

Rev. Growth (Yr)

27.04%

Rev. Growth (Qtr)

9.96%

VCEL Earnings

Earnings (TTM)

3.5M

Earnings Growth (Yr)

75.38%

Earnings Growth (Qtr)

80.76%

VCEL Profitability

EBT Margin

7.00%

Return on Equity

1.38%

Return on Assets

0.91%

Free Cashflow Yield

-0.43%

VCEL Investor Care

Shares Dilution (1Y)

3.42%

Diluted EPS (TTM)

0.08

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	207.8M	214.5M	226.8M	0
2023	169.3M	178.2M	185.2M	197.5M
2022	157.7M	155.2M	159.3M	164.4M
2021	132.1M	151.6M	153.8M	156.2M
2020	122.7M	116.6M	118.3M	124.2M
2019	94.6M	101.8M	109.8M	117.8M
2018	72.6M	74.6M	82.9M	90.9M
2017	56.5M	60.6M	63.9M	63.9M
2016	54.4M	53.7M	53.3M	61.2M
2015	39.6M	48.8M	50.5M	51.2M
2014	0	17.3M	23.0M	28.8M
2013	27.0K	30.0K	5.8M	11.5M
2012	11.0K	11.0K	2.0K	21.0K
2011	53.5K	41.7K	29.8K	18.0K
2010	0	89.0K	77.2K	65.3K
2009	0	182.0K	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

CEO	Mr. Dominick C. Colangelo Esq.
WEBSITE	https://vcel.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	305

Vericel Corp Frequently Asked Questions

What is the ticker symbol for Vericel Corp? What does VCEL stand for in stocks?

VCEL is the stock ticker symbol of Vericel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vericel Corp (VCEL)?

As of Fri Dec 20 2024, market cap of Vericel Corp is 2.79 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers.

Is Vericel Corp a good stock to buy?

The fair value guage provides a quick view whether VCEL is over valued or under valued. Whether Vericel Corp is cheap or expensive depends on the assumptions which impact Vericel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VCEL.

What is Vericel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, VCEL's PE ratio (Price to Earnings) is 786.01 and Price to Sales (PS) ratio is 12.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VCEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Vericel Corp's stock?

In the past 10 years, Vericel Corp has provided 0.348 (multiply by 100 for percentage) rate of return.